$YCBD
cbdMD, Inc. Stock $ycbd

$ycbd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000143774922029136 Filed on December 15, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$6.085M	$7.860M	$35.40M
YoY Change	-34.72%	-19.75%	-20.41%
Cost Of Revenue	$2.517M	$2.891M	$13.07M
YoY Change	-41.84%	-28.64%	-9.85%
Gross Profit	$3.568M	$4.969M	$22.34M
YoY Change	-28.55%	-13.47%	-25.51%
Gross Profit Margin	58.63%	63.22%	63.09%
Selling, General & Admin	$5.442M	$6.556M	$34.01M
YoY Change	-49.83%	-42.89%	-24.07%
% of Gross Profit	152.54%	131.93%	152.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$100.1K	$456.0K	$949.0K
YoY Change	-70.62%	53.24%	-6.73%
% of Gross Profit	2.81%	9.18%	4.25%
Operating Expenses	$6.729M	$7.956M	$39.65M
YoY Change	-43.71%	-37.62%	-20.07%
Operating Profit	-$4.046M	-$2.987M	-$78.27M
YoY Change	-83.91%	-57.4%	298.99%
Interest Expense	$29.12K	$23.12K	-$17.10K
YoY Change	-179.61%	58.57%	-103.3%
% of Operating Profit
Other Income/Expense, Net	$0.00	$101.9K	$239.3K
YoY Change	-100.0%	245.56%	711.57%
Pretax Income	-$3.956M	-$14.63M	-$70.08M
YoY Change	-79.35%	363.56%	188.53%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.956M	-$14.63M	-$70.08M
YoY Change	-79.35%	401.58%	199.57%
Net Earnings / Revenue	-65.01%	-186.16%	-197.96%
Basic Earnings Per Share	-$0.08		-$1.24
Diluted Earnings Per Share	-$0.08	-$238.6K	-$1.24
COMMON SHARES
Basic Shares Outstanding	60.68M	60.56M	59.75M
Diluted Shares Outstanding	60.36M		59.75M

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.353M	$7.720M	$7.720M
YoY Change	-78.97%	-70.81%	-71.87%
Cash & Equivalents	$3.353M	$6.720M	$6.720M
Short-Term Investments	$1.000M	$1.000M	$1.000M
Other Short-Term Assets	$1.587M	$2.588M	$2.588M
YoY Change	-47.19%	-11.45%	-11.45%
Inventory	$4.861M	$4.767M	$4.256M
Prepaid Expenses
Receivables	$265.5K	$273.5K	$1.448M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.53M	$16.01M	$16.01M
YoY Change	-61.15%	-56.14%	-56.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$900.6K	$823.3K	$5.301M
YoY Change	-64.04%	-67.86%	-35.17%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles	$17.56M	$17.83M
YoY Change	-5.94%	-22.47%
Long-Term Investments	$1.400M	$1.400M	$1.400M
YoY Change
Other Assets	$138.7K	$244.6K	$244.6K
YoY Change	-65.98%	-53.81%	-53.81%
Total Long-Term Assets	$24.20M	$24.78M	$24.78M
YoY Change	-65.26%	-71.96%	-71.96%
TOTAL ASSETS
Total Short-Term Assets	$11.53M	$16.01M	$16.01M
Total Long-Term Assets	$24.20M	$24.78M	$24.78M
Total Assets	$35.73M	$40.79M	$40.79M
YoY Change	-64.03%	-67.34%	-67.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.690M	$2.037M	$2.037M
YoY Change	-54.01%	-31.63%	-31.63%
Accrued Expenses	$2.650M	$2.061M	$3.239M
YoY Change	-12.43%	-24.45%	-16.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.760K	$9.610K	$9.610K
YoY Change	-83.86%	-83.84%	-83.84%
Total Short-Term Liabilities	$5.552M	$5.286M	$5.286M
YoY Change	-17.87%	-23.59%	-23.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$125.5K	$125.5K
YoY Change	-100.0%	15.15%
Other Long-Term Liabilities	$3.584M	$3.956M	$3.956M
YoY Change	-55.61%	-73.31%	-73.31%
Total Long-Term Liabilities	$3.584M	$4.082M	$4.082M
YoY Change	-56.11%	-72.46%	-72.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.552M	$5.286M	$5.286M
Total Long-Term Liabilities	$3.584M	$4.082M	$4.082M
Total Liabilities	$9.136M	$9.367M	$9.367M
YoY Change	-38.79%	-56.91%	-56.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.4M	-$147.4M
YoY Change	62.97%	101.02%
Common Stock	$60.71K	$60.67K
YoY Change	4.18%	4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.59M	$31.42M	$31.42M
YoY Change
Total Liabilities & Shareholders Equity	$35.73M	$40.79M	$40.79M
YoY Change	-64.03%	-67.34%	-67.34%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	-$3.956M	-$14.63M	-$70.08M
YoY Change	-79.35%	401.58%	199.57%
Depreciation, Depletion And Amortization	$100.1K	$456.0K	$949.0K
YoY Change	-70.62%	53.24%	-6.73%
Cash From Operating Activities	-$2.064M	-$1.926M	-$14.97M
YoY Change	-62.25%	-55.57%	6.2%
INVESTING ACTIVITIES
Capital Expenditures	$177.4K	$95.56K	$688.7K
YoY Change	-176.77%	-413.93%	-301.36%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$177.4K	$95.56K	-$688.7K
YoY Change	-23.23%	-104.71%	-73.01%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.001M
YoY Change	0.0%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.126M	-1.003M	-$4.035M
YoY Change	10.92%	-107.27%	-114.29%
NET CHANGE
Cash From Operating Activities	-$2.064M	-1.926M	-$14.97M
Cash From Investing Activities	-$177.4K	95.56K	-$688.7K
Cash From Financing Activities	-$1.126M	-1.003M	-$4.035M
Net Change In Cash	-$3.368M	-2.833M	-$19.69M
YoY Change	-49.85%	-138.15%	-269.95%
FREE CASH FLOW
Cash From Operating Activities	-$2.064M	-$1.926M	-$14.97M
Capital Expenditures	$177.4K	$95.56K	$688.7K
Free Cash Flow	-$2.242M	-$2.021M	-$15.66M
YoY Change	-57.2%	-53.04%	13.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60665595
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	108985	usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60665595
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57783340
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57783340
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60665595
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57783340
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38299
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3414576
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	8845 Red Oak Blvd
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28217
CY2022	dei	City Area Code CityAreaCode	704
CY2022	dei	Local Phone Number LocalPhoneNumber	445-3060
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	42426087	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60682262
CY2022	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2022	dei	Auditor Firm AuditorFirmId	677
CY2022	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2022	dei	Auditor Location AuditorLocation	Charlotte, North Carolina
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6720234	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26411424	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1447831	usd
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1113372	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	1375	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	10967	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	33351	usd
CY2022Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000000	usd
CY2021Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000000	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	4255914	usd
CY2021Q3	us-gaap	Inventory Gross InventoryGross	5021867	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2021Q3	ycbd	Prepaid Inventory PrepaidInventory	551519	usd
CY2022Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	1372845	usd
CY2021Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	1212682	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	701945	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1147178	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	16011603	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	36502360	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2561574	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4477841	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5614960	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	244606	usd
CY2021Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	529583	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23003929	usd
CY2022Q3	us-gaap	Goodwill Goodwill	0	usd
CY2021Q3	us-gaap	Goodwill Goodwill	56670970	usd
CY2022Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	1400000	usd
CY2021Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	0	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	24780306	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	88381016	usd
CY2022Q3	us-gaap	Assets Assets	40791909	usd
CY2021Q3	us-gaap	Assets Assets	124883376	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2036558	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2978914	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2060762	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2727612	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1178683	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1151150	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9609	usd
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	59470	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5285612	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6917146	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125491	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3680375	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4859058	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	276000	usd
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9856000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4081866	usd
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14824043	usd
CY2022Q3	us-gaap	Liabilities Liabilities	9367478	usd
CY2021Q3	us-gaap	Liabilities Liabilities	21741189	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	60666	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	57783	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178782328	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	176417269	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147423563	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73337865	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	103142187	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40791909	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124883376	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37122215	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47332085	usd
CY2022	ycbd	Sales Allowances SalesAllowances	1718991	usd
CY2021	ycbd	Sales Allowances SalesAllowances	2851322	usd
CY2022	us-gaap	Revenues Revenues	35403224	usd
CY2021	us-gaap	Revenues Revenues	44480763	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	13066639	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	14495063	usd
CY2022	us-gaap	Gross Profit GrossProfit	22336585	usd
CY2021	us-gaap	Gross Profit GrossProfit	29985700	usd
CY2022	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	39647130	usd
CY2021	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	49601690	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	60955970	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-78266515	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-19615990	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-33350	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	546878	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1466113	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	88769	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	602092	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	-0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8473999	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6687439	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	239250	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29479	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16246	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28930	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-70083693	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24289889	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-895000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23394889	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2554609	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74085698	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25949498	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59750301
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54938128
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59750301
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54938128
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23394889	usd
CY2022	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-70083693	usd
CY2021	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-23394889	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2554609	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-74085698	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25949498	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23394889	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	555215	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1298106	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	373610	usd
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	1626613	usd
CY2022	ycbd	Marketing Stock Amortization MarketingStockAmortization	907774	usd
CY2021	ycbd	Marketing Stock Amortization MarketingStockAmortization	871390	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	97720	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	878142	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	670580	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	884380	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022	us-gaap	Depreciation Depreciation	948962	usd
CY2021	us-gaap	Depreciation Depreciation	1017408	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	60955970	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	322017	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8473999	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6687439	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-33350	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	546878	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	196896	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1466113	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1137119	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1236397	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-65541	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	183735	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-284977	usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-261125	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	112189	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1009192	usd
CY2022	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-40060	usd
CY2021	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	263341	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	289586	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-525670	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1812547	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-104422	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1151152	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1159097	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	203341	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3723	usd
CY2022	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	9592	usd
CY2021	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	436167	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-0	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	895000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14967150	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14093433	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	540000	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	-0	usd
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	750000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	688680	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	342013	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-688680	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2552013	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	30938386	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-33355	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-151551	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4002005	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	2554609	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4035360	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28232226	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19691190	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11586780	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26411424	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14824644	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6720234	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26411424	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2364	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	33693	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	103142187	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	405000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	508754	usd
CY2021Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	84400000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	661000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	328514	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4657215	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	80023429	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	178000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-373168	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-593617	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-31634143	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	46600000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	198000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	128404	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	129960	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-14631432	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	79182048	usd
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15798115	usd
CY2020Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	219875	usd
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-0	usd
CY2020Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	15279	usd
CY2020Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	100050	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-9395621	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	85719646	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11426200	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	627648	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1181828	usd
CY2021Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	560279	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12510474	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	85884569	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1472600	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	355565	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	590292	usd
CY2021Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	560281	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1537288	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	89280033	usd
CY2021Q3	ycbd	Common Stock Issued During Period Value New Issues CommonStockIssuedDuringPeriodValueNewIssues	0	usd
CY2021Q3	ycbd	Preferred Stock Issued During Period Value New Issues PreferredStockIssuedDuringPeriodValueNewIssues	15144771	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	493000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	479899	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1184265	usd
CY2021Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1333999	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	103142187	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, expected sales returns and allowances, certain assumptions related to the valuation of investments other securities, acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets and income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities and contingent liability. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <em style="font: inherit;"> March 11, 2020, </em>the World Health Organization declared the COVID-<em style="font: inherit;">19</em> outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<em style="font: inherit;">19</em> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restriction on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. We continue to monitor the waning trends on infection rates and are cautiously optimistic future impacts to the business environment will be minimal.</p>
CY2021Q3	us-gaap	Goodwill Goodwill	56670970	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36980	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3633	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	273451	usd
CY2021Q3	ycbd	Prepaid Inventory PrepaidInventory	551519	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	56670970	usd
CY2022Q3	us-gaap	Goodwill Goodwill	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M8D
CY2021	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	293984
CY2022Q3	us-gaap	Inventory Net InventoryNet	4767373	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	5573386	usd
CY2021Q4	us-gaap	Inventory Write Down InventoryWriteDown	878142	usd
CY2021Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	43000	usd
CY2021	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	3.75
CY2021	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	323444
CY2021	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	1.25
CY2021	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	224307
CY2021	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	5.39
CY2022	us-gaap	Revenues Revenues	35403224	usd
CY2021	us-gaap	Revenues Revenues	44480763	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	14332235	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	15835139	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	602092	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers $250,000 for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $5,752,550 uninsured balance at <em style="font: inherit;"> September 30, 2022</em> and a $23,508,953 uninsured balance at <em style="font: inherit;"> September 30, 2021</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c91914750">not</span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2022</em>.</p>
CY2021	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5752550	usd
CY2021Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	23508953	usd
CY2022	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0
CY2022	ycbd	Net Income Loss Including Impairment NetIncomeLossIncludingImpairment	-74086731	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	60955970	usd
CY2022	ycbd	Net Income Loss Excluding Impairment NetIncomeLossExcludingImpairment	-13130761	usd
CY2022Q3	ycbd	Working Capital WorkingCapital	10725991	usd
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	70206	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	33350	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	546878	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1260000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.63
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3198488	usd
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3362897	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1213724	usd
CY2021Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1729176	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	156298	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2502500
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1549167
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.13
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1877671	usd
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4425348	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1054361	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1863774	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2561574	usd
CY2022	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	948962	usd
CY2021	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	1017408	usd
CY2021Q3	us-gaap	Goodwill Goodwill	56670970	usd
CY2021Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13898285	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	30776436	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11996249	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4285000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-0	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	932862	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	48482	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23003929	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1109418	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1109418	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1074634	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	942457	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	942457	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12656165	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17834549	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60665595
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57783340
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	466713
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	25000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	323444
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-895000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1750000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.68
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1380000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.91
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	147953
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	279547
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.47
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2702500
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.42
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M17D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1060000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.97
CY2022	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	-0
CY2022	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	70500
CY2022	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	4.00
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	589917
CY2022Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.68
CY2022Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P2Y3M18D
CY2022Q3	ycbd	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	589917
CY2022Q3	ycbd	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	4.68
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-895000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-895000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16373000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13046000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	257000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	219000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1391856	usd
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	1405887	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M28D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0466	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1380204	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1421610	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1159949	usd
CY2022Q3	ycbd	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	1372862	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5334625	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	475567	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4859058	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1405887	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1380204	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1421610	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1159949	usd
CY2021Q3	ycbd	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	1372862	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6740512	usd
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	730304	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6010208	usd
CY2021Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	35000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	16000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	52000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	45000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-23394889	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2554609	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-74085698	usd
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-25949498	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74085698	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25949498	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-74085698	usd
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-25949498	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-74085698	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-25949498	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59750301
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54938128
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59750301
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54938128
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.47
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.47
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.171	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.015	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.025	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.068	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.138	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.037	pure
CY2018Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	2100000	usd
CY2018Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	500000	usd
CY2021Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	11400000	usd
CY2021Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	2700000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4758000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12909000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9160000	usd
CY2022Q3	ycbd	Right Of Use Liability RightOfUseLiability	1087000	usd
CY2021Q3	ycbd	Right Of Use Liability RightOfUseLiability	1342000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	702000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	716000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	833000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1107000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	452000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	444000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	214000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	165000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	40000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1002000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1254000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3426000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4481000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-0	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	162000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4685000	usd
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6116000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11688000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6930000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11688000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6930000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3351000	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	57700000	usd
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4600000	usd
CY2021Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	2000000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	600000
CY2021Q3	us-gaap	Escrow Deposit EscrowDeposit	200000	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	300000
CY2021Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	100000
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	200000
CY2021Q3	ycbd	Lock Up Agreement Period LockUpAgreementPeriod	P180D
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	300000
CY2021Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	100000
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1064000	usd
CY2022Q3	ycbd	Consideration Consideration	3552529	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	18155	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	79895	usd
CY2022Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	31094	usd
CY2022Q3	ycbd	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property And Equipment Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipmentNet	5000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	3418383	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	3552529	usd

Files In Submission

Name	View Source	Status
0001437749-22-029136-index-headers.html	Edgar Link	pending
0001437749-22-029136-index.html	Edgar Link	pending
0001437749-22-029136.txt	Edgar Link	pending
0001437749-22-029136-xbrl.zip	Edgar Link	pending
ex_399187.htm	Edgar Link	pending
ex_399188.htm	Edgar Link	pending
ex_399190.htm	Edgar Link	pending
ex_399191.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ycbd-20220930.xsd	Edgar Link	pending
ycbd20220930_10k.htm	Edgar Link	pending
ycbd_10kimg20.jpg	Edgar Link	pending
ycbd_10kimg21.jpg	Edgar Link	pending
ycbd_10klogo.jpg	Edgar Link	pending
ycbd-20220930_def.xml	Edgar Link	unprocessable
ycbd-20220930_cal.xml	Edgar Link	unprocessable
ycbd-20220930_pre.xml	Edgar Link	unprocessable
ycbd-20220930_lab.xml	Edgar Link	unprocessable
ycbd20220930_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YCBD
cbdMD, Inc. Stock $ycbd

2022 Q4 Form 10-K Financial Statement

#000143774922029136 Filed on December 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD cbdMD, Inc. Stock $ycbd

2022 Q4 Form 10-K Financial Statement

#000143774922029136 Filed on December 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD
cbdMD, Inc. Stock $ycbd